ASXL1 and myelodysplastic syndrome: This is supported by a study that evaluated chromosomal microarray in 30 MDS patients with del(20q), and found 2/3 of patients had intact ASXL1 gene and only 1/3 of patients had partial/entire ASXL1 deletion10.